Obagi Medical Products, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Obagi Medical Products, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Obagi Medical Products, Inc.. The Group's principal activity is to develop and market prescription-based, topical skin health systems in the aesthetic and therapeutic skin health markets. It helps physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper pigmentation, acne and soft tissue deficits, such as fine lines and wrinkles. Its product lines are prescription-based skin health systems that improve the efficacy of established prescription and over-the-counter, therapeutic agents by enhancing the penetration of these agents across the skin barrier using proprietary technologies. It also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based Pharmaceutical company. The Group introduced ELASTIdermTM product line, ELASTIdermTM Eye Cream, a for treatment of skin laxity around the eye.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report